References
- Meyer D, Pietu G, Fressinaud E, Girma J P. Von Willebrand Factor: Structure and Function. Mayo Clin Proc 1991; 66: 516–23
- Barrowcliffe T W., Edwards S J., Kemball-Cook G, Thomas D P. Factor VIII degradation products in heated concentrates. The Lancet 1986; i: 1448–49
- Wadsworth C, Hanson L A., Kjellman H, Søderstrøm T, Blomback M. Some characteristics of aggregates of IgG and plasma proteins in heat treated factor VIII concentrates. Blut 1989; 58: 133–41
- Dawes J, Freeman L, Dawson N J., Pepper D S., Barrowcliffe T W. High Molecular Weight Content of Heated and Unheated Factor VIII Products Determined by Fast-Protein Liquid Chromatography. Vox Sang 1991; 58: 330–4
- Thomas K B., Mc Grath K M., Taylor M, Young I F., Herrington R W., Schiff P. Effect of virucidal heat-treatment on proteins in human factor VIII concentrates. Transfusion 1987; 28: 8–13
- Bukh A, Ingerslev J, Stenbjerg S, Hundahl Møller N P. The multimeric structure of plasma F VIII: RAg studied by electroelution and immunoperoxidase detection. Throm Res 1986; 43: 579–84
- Ingerslev J. A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest 1987; 47: 143–9
- Procyk R, Adamson L, Block M, Blomback B. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers–a thiol enhanced process. Throm Res 1985; 40: 833–52